Aarti Pharmalabs Ltd.

The revenue for the June 2025 quarter is pegged at Rs. 3753.11 millions against Rs. 3934.86 millions recorded during the year-ago period.A slim rise of 8.65% was recorded in the Net profit for the quarter ended June 2025 to Rs. 512.20  millions  From Rs. 471.43 millions.The company reported a good operating profit of 967.25 millions compared to 857.67 millions of corresponding previous quarter.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202506	202406	% Var	202506	202406	% Var	202503	202403	% Var
Sales	3753.11	3934.86	-4.62	3753.11	3934.86	-4.62	17713.52	15021.32	17.92
Other Income	15.96	21.13	-24.47	15.96	21.13	-24.47	144.90	110.09	31.62
PBIDT	967.25	857.67	12.78	967.25	857.67	12.78	4410.34	3571.68	23.48
Interest	67.95	42.49	59.92	67.95	42.49	59.92	256.33	166.35	54.09
PBDT	899.30	815.18	10.32	899.30	815.18	10.32	4154.01	3405.33	21.99
Depreciation	227.57	182.93	24.40	227.57	182.93	24.40	790.59	660.14	19.76
PBT	671.73	632.25	6.24	671.73	632.25	6.24	3363.42	2745.19	22.52
TAX	159.53	160.82	-0.80	159.53	160.82	-0.80	789.92	738.74	6.93
Deferred Tax	33.33	45.15	-26.18	33.33	45.15	-26.18	222.81	278.17	-19.90
PAT	512.20	471.43	8.65	512.20	471.43	8.65	2573.50	2006.45	28.26
Equity	453.17	453.13	0.01	453.17	453.13	0.01	453.17	453.13	0.01
PBIDTM(%)	25.77	21.80	18.24	25.77	21.80	18.24	24.90	23.78	4.71